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Objective: Osmolarity is a major biophysical regulator of chondrocyte function. Modulation of chon-
drocytic marker gene expression occurs at the post-transcriptional level following exposure of human
articular chondrocytes (HAC) to hyperosmotic conditions. This study aims to further characterise the
post-transcriptional response of HAC to hyperosmolarity.
Methods: Gene expression and microRNA (miRNA) levels in freshly isolated HAC after 5 h under control
or hyperosmotic conditions were measured using microarrays. Regulated genes were checked for the
presence of AU rich elements (AREs) in their 30 untranslated regions (30UTR), whilst gene ontology was
examined using Ingenuity Pathway Analysis (IPA). RNA decay rates of candidate ARE-containing genes
were determined in HAC using actinomycin D chase experiments and the involvement of the p38
mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinases 1 and 2 (ERK1/2)
pathways were investigated using pharmacological inhibitors.
Results: Hyperosmolarity led to the regulation of a wide variety of genes. IPA identiﬁed enrichment of
genes involved with cell stress responses, cell signalling and transforming growth factor b (TGFb) sig-
nalling. Importantly, upregulated genes were over-represented with those containing AREs, and RNA
decay analysis demonstrated that many of these were regulated post-transcriptionally by hyper-
osmolarity in HAC. Analysis of miRNA levels in HAC indicated that they are only modestly regulated by
hyperosmotic conditions, whilst inhibitor studies showed that p38 MAPK and ERK1/2 were able to block
hyperosmotic induction of many of these genes.
Conclusion: Through microarray and bioinformatics analysis we have identiﬁed genes which are post-
transcriptionally regulated in HAC following exposure to hyperosmotic conditions. These genes have
a range of functions, and their regulation involves transduction through the p38 MAPK and ERK1/2
pathways. Interestingly, our results suggest that miRNA regulation is not key to the process. Overall, this
work illustrates the range of processes regulated in chondrocytes by changes in their osmotic environ-
ment, and underlines the importance of post-transcriptional mRNA regulation to chondrocyte function.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Within articular cartilage, chondrocytes populate a challenging
environment. This is due to the tissue’s lack of vascularisation and
polyanion-rich extracellular matrix (ECM) and is characterised by
low oxygen tension, low pH, high osmotic pressure and low
nutrient levels1. Furthermore, articular cartilage is subjected to
substantial compressive and shear forces during locomotion and
chondrocyte phenotype and activity can be regulated by changes in
many of these biophysical parameters. It is well established thatSimon R. Tew, Department of
ronic Disease, University of
4 7TE, UK. Tel: 44-(0)-151-
s Research Society International. Pdynamicmechanical compression leads to elevation of chondrocyte
marker gene expression and enhanced ECM production2,3. Addi-
tionally, many chondrocyte functions are regulated by changes
within the physiochemical environment and alterations in ECM
synthesis are driven by changes in pH, oxygen tension and also
osmolarity4e7.
The responses of chondrocytes to osmolarity in particular have
been long studied. Synthesis of glycosaminoglycan and collagen by
articular cartilage explants is improved under hyperosmotic
conditions with an osmolarity of around 350e400 mOsm appear-
ing to be optimal8. These levels correspond to the osmolarity found
within healthy articular cartilage although the tissue would expe-
rience higher osmolarities when subjected to compression9. We
have recently shown that hyperosmotic conditions are able toublished by Elsevier Ltd. All rights reserved.
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mobility group box (SOX9) and COL2A1 in a process that involves
altered post-transcriptional regulation of the mRNA molecules that
encode these genes10.
Post-transcriptional mRNA control is an important tier of the
gene regulation that is co-ordinated by RNA binding proteins and
microRNAs (miRNAs)11e13. The mRNAs which are regulated in this
way often contain AU rich elements (AREs) within their 30 untrans-
lated regions (30UTRs) and a number of different classes of these
elements have been identiﬁed through their structural and func-
tional similarities14,15. Control of genes at the post-transcriptional
level has been shown to be important in modulating the expres-
sion of genes involved in immune response, angiogenesis cell sig-
nalling and cell division. A wide variety of parameters including cell
stress, differentiation and growth factor/cytokine stimulation
contribute to altered rates of mRNA turnover16. It is therefore likely
that post-transcriptional gene control is a ubiquitous means of
controlling a wide variety of genes in tissues throughout the body.
The extent and nature of post-transcriptional gene control in
chondrocytes is very poorly understood. Prior to our ﬁndings that
hyperosmolarity regulates SOX9mRNA decay, we demonstrated that
cellular stress induced by cycloheximide treatment has a similar
effect. Other groups have also presented evidence that mRNAs
encoding bone morphogenetic protein 2 and inducible nitric oxide
synthasecanbecontrolledpost-transcriptionally inchondrocytes17,18.
We were interested in what the scope of post-transcriptional gene
control in chondrocytes might be. We therefore conducted a micro-
arrayscreentoexaminegenes regulatedbyhyperosmolarityandthen,
using in silico and in vitro approaches, identiﬁed genes whose regu-
lation involved alterations in their mRNA decay rates.
Materials and methods
Cell culture
Osteoarthritic human articular cartilage was obtained following
total knee arthroplastywith full approval from the Cheshire Research
Ethics Committee. Primaryarticular chondrocyteswere isolated from
tissue, dissected from intact, non-ﬁbrillated areas of the articular
surface, by overnight digestion in Dulbecco’s Modiﬁed Eagles
Medium (DMEM) containing 10% Foetal Bovine Serum (FBS),
100 units/ml penicillin, 100 units/ml streptomycin, 5 mg/ml ampho-
tericin B and 0.08% collagenase type II (all from Invitrogen). Freshly
isolated cellswereplatedathighdensity (1105 cells/cm2) in25 cm2
ﬂasks in the samemediawithout collagenase and used 24 h later. The
primary chondrocytes were treated with DMEMwithout serum and
adjusted to 380 mOsm through the addition of NaCl for 2 h to accli-
matise them to serum free conditions. Then the media was changed
either to 380 or 550 mOsm in serum freemedia for 5 h before the cell
layers were extracted using Tri Reagent. Osmolarity of media was
conﬁrmed using a Loess Freezing point osmometer. All cell culture
was carried out at 37 C in a 5% CO2 environment. For mitogen-
activated protein kinase (MAPK) inhibitor experiments, 20 mM of
SB202190 (p38 MAPK inhibitor) or U0126 (MEK1 inhibitor) were
added to the cultures during the 2-h 380 mOsm acclimatisation
period and maintained during subsequent 5 h 380 or 550 mOsm
incubations. Total RNAwas puriﬁed from all primary chondrocyte Tri
Reagent lysates using a standard chloroform extraction/isopropanol
precipitation procedure before reconstitution in Ribonuclease
(RNAse)-free water.
Microarray analysis
RNA was sent to The Genome Centre, Queen Mary University
London and was used to probe an Illumina Ref8 v.3 ExpressionBeadchip for gene expression analysis and a Universal 12 v2 1536
Bead Array for quantiﬁcation of miRNAs. RNA from four donors was
analysed with one array per donor. RNA integrity was conﬁrmed
using an Agilent bioanalyser and it was then labelledwith Cy3 using
an Ambion TotalPrep kit before being hybridised to arrays using an
Illumina Beadstation 500G. The arrays were then scanned with an
Illumina Bead Array reader and data imported into Illumina Bead-
Studio software for normalisation. Microarray data was submitted
in MAGE-TAB format for curation at ArrayExpress (http://www.ebi.
ac.uk/miamexpress) with the accession numbers E-MEXP-3129
(gene expression) and E-MTAB-654 (miRNA expression). Gene
expression data from the Ref8 Beadchip was imported into MaxD
softwarewhere fold changes in mRNA level due to hyperosmolarity
were determined for each donor. Data from both array platforms
was also imported intomultiple experiment viewer softwarewhere
statistical analysis and hierarchical clustering was conducted.
mRNAs exhibiting up or down regulation in all four donors were
then taken and screened against the human AU rich element
database (ARED e http://brp.kfshrc.edu.sa/ARED/) to detect the
presence of 30UTR regulatory elements which could predispose the
mRNAs to post-transcriptional regulation19.
Ingenuity Pathway Analysis (IPA)
IPA (Ingenuity Systems, Redwood City, CA) was applied to two
data sets: (1) a list of 858 differentially expressed genes exhibiting
1.4-fold regulation of expression values, P< 0.05 and (2) a list of
genes differentially expressed by at least 1.1-fold P value <0.05.
Gene symbols have been used as Identiﬁers and Ingenuity Knowl-
edge Base gene set as a reference for a pathway analysis. ‘Canonical
Pathways’ and ‘Networks’ were ranked by IPA according to statis-
tical signiﬁcance of their coverage.
Real time PCR
cDNA was generated by reverse transcription using moloney
murine leukemia virus (MMLV) reverse transcriptase primed with
random hexamers (Promega). Real time polymerase chain reaction
(PCR) was performed on an Applied Biosystems 7300 instrument
using SYBR Green Mastermix (Applied Biosystems, Warrington,
UK). Gene expression levels were normalised to glyceraldehyde
3-phosphate dehydrogenase (GAPDH) levels using the 2DCT
method. The PCR reaction efﬁciencies of all new primers pairs was
determined andwere found to bewithin 10% of the efﬁciency of the
GAPDH primers. The primer pairs used in this study are listed in
Supplemental Table I. Real time PCR analysis data was log trans-
formed to ensure normal distribution and then analysed using
paired t tests.
RNA decay analysis
RNA decay experiments were conducted in primary human
articular chondrocytes (HAC) cultured for up to 4 h with the RNA
polymerase inhibitor actinomycin D (1 mM) with Tri Reagent
extracts taken at 0, 1, 2 and 4 h. For RNA decay experiments, gene
expression values calculated by real time PCR were normalised to
time 0 and plotted against the time with actinomycin D on semilog
graphs. The exponential slope was used to determine RNA half-life
using the equation t1/2¼ ln(2)/slope.
Western blot analysis
Chondrocyte cell lysates were extracted using 1 sodium
dodecyl sulphate (SDS) sample buffer, separated on 4e12% NuPAGE
gels (Invitrogen) and blotted onto nitrocellulose. Blots were probed
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(ERK1/2), total ERK1/2 and phospho p38 MAPK antibodies
(Cell Signalling Technologies) or GAPDH antibody (Sigma) using
previously described protocols10.
Statistical analysis
Comparisons between control and hyperosmotic conditions for
the microarray datasets was carried out using paired Student’s
t tests. For IPA the signiﬁcance of the association between the data
set and the canonical pathway was measured in two ways: (1) a
ratio of the number of molecules from the data set that map to the
pathway divided by the total number of molecules that map to the
canonical pathway. (2) Fisher’s exact test was used to calculate
a P value determining the probability that the association between
the genes in the data set and the canonical pathway is explained by
chance alone. Real time PCR data was subject to log10 trans-
formation before treated and control samples were compared using
paired Student’s t tests.
Results
Hyperosmolarity regulates many genes in HAC
We examined the effect of hyperosmotic stimulation on gene
expression using chondrocytes freshly isolated from the articular
cartilage of four human donors (three female, one male, average age
80 years 8 years standard deviation). We isolated RNA from HAC
following 5 h exposure to hyperosmotic conditions and conducted
qRT-PCR. Initial analysis of these samples demonstrated that SOX9
mRNA was signiﬁcantly upregulated in hyperosmotic cultures with
an average change of 1.6-fold (380 mOsm 2DCt value¼ 0.20 0.07
95% conﬁdence interval, 550 mOsm 2DCt value¼ 0.33 0.11 95%
conﬁdence interval, P¼ 0.05, using paired t test, n¼ 4) which was
comparable to our previous ﬁndings10. We therefore carried out
microarray analysis of primary HAC to examine their responses to
hyperosmolarity at the transcriptomic level. Principal components
analysis of the raw array data demonstrated that themajor inﬂuence
on the variability of the data was fromwhichever osmotic condition
the cells were cultured in. Donor to donor variability was
a secondary component but its inﬂuence was at a much lower
magnitude. The data was normalised and spot intensities were used
to create fold changes for each gene. We initially examined genes
that were most strongly regulated by hyperosmolarity. Overall we
identiﬁed 88 genes that were upregulated, and 51 genes that were
downregulated, by at least twofold in both instances. The 30 most
strongly up and downregulated genes are presented in Table I. We
found that a number of genes with well established functions in
cartilage biology were upregulated by hyperosmotic culture condi-
tions. These included PTGS2 cyclo-oxygenase-2 (COX2) and IL6,
which exhibited strong upregulation in each donor but also high
variability in overall levels between donors. Other notable genes,
which were outside the top 30 but nevertheless exhibited greater
than twofold upregulation, were ADAMTS1 and SLC5A3 (which
encodes the osmosensitive myoinositol transporter SMIT), which
were increased on average by 2.36- and 2.53-fold respectively.
Genes upregulated by hyperosmolarity over-represented with those
containing AREs
We examined whether the regulated genes contained potential
RNA destabilising 30UTR regulatory regions using the ARED database.
We found that over a third of the 30 highest upregulated genes
contained putative AREs in their 30UTRs (Table I). The AREs were
mainlyof theAREDdeﬁned cluster 3 or5 family. Conversely, only fourof the 30most highly downregulated genes contained suchelements,
all ofwhichwere cluster 5.We expanded this analysis to examine the
prevalence of AREs in all genes upregulated by any magnitude but
with a P value< 0.01 [Fig. 1(A)]. We found that, compared to the
prevalence of AREs within thewhole genome, the genes upregulated
in our study were over-represented with those containing AREs,
particularly those of the cluster 5 subtype. Whilst 6.7% of the entire
genome consists of ARE-containing genes, 26.7% of the hyper-
osmotically regulated genes that we identiﬁed contained these
elements. Hierarchical cluster analysis, performed on the signiﬁ-
cantly upregulated genes identiﬁed clusters of transcripts whose
responses were similar from donor to donor following hyperosmotic
stimulation. However, there was no obvious enrichment of
ARE-containing genes within any particular cluster [Fig. 1(B)].
IPA
To explore the nature of the genes regulated by hyperosmolarity
in HAC we performed ontology analysis using IPA. We analysed
signiﬁcantly differentially expressed genes with either at least
a 1.4-fold change in expression or a 1.1-fold change. Statistical
signiﬁcance (P value) of Top 5 Canonical Pathways coverage was
estimated in a range of 2.68E05 to 3.5E04 for the 1.4-fold gene
set and 6E07 to 8.3E06 for the 1.1-fold gene set. We found that
when examining only the 1.4-fold regulated genes, hyperosmotic
conditions caused a signiﬁcant enrichment in regulation of genes
involved in, among others, MAPK pathways (p38 MAPK, ERK1/2) as
well as within vitamin D receptor (VDR), hepatocyte growth factor
(HGF) and transforming growth factor b (TGFb) signalling pathways
(Table II). Expansion of the IPA analysis to include genes only
modestly regulated by hyperosmolarity (1.1-fold change) revealed
enrichment of genes mapping strongly to a range of pathways
including; calcium signalling, glycolytic and the nuclear factor
kappa-light-chain-enhancer of activated B cells (NFkB) signalling
pathways (not shown). In keeping with the stressful nature of the
hyperosmotic conditions to the chondrocytes, there was also
regulation of most of the components of the branched amino acid
synthetic pathway, as well as regulation of the related mTor sig-
nalling pathway e both known cellular stress response mecha-
nisms. Given the important role that TGFb signalling plays in
chondrocyte biology we performed a detailed examination of the
components of TGFb signalling regulated by hyperosmolarity
(Fig. 2). This showed that extracellular ligands such as TGFb3 were
upregulated as were downstream transcriptional regulators such as
TGIF and TFE3 (Table II). However expression of signalling inter-
mediates such as the receptor TGFBR2 and the signalling molecules
SMAD3 and SMAD6 was downregulated (Table II).
Many genes upregulated by hyperosmolarity are
post-transcriptionally controlled
We decided to focus on 15 of the genes that were strongly upre-
gulated by hyperosmolarity. Thirteen of the genes we chose contain
ARED-identiﬁed AREs within their 30, one (SGK) harbours four
AUUUAmotifs,whichwere identiﬁedmanually, and another (ARNTL)
is strongly upregulated (5.1-fold) but contains no AREs. Using reverse
transcription and real time PCR analysis we examined the original
RNA samples used to perform the microarray experiment to conﬁrm
the regulation of these genes. The efﬁciency of all primer pairs used
was measured and they were all found to be comparable with the
primers used to amplify the housekeeping gene GAPDH. We found
that, with one exception (SLC5A3), the PCR measurements showed
a signiﬁcant upregulation of the genes in the hyperosmotic condi-
tions, conﬁrming the microarray ﬁndings [Fig. 1(C)]. We then
examined RNA decay rates in freshly isolated HAC from two donors
Table I
30 Most strongly up and downregulated genes in freshly isolated HAC following exposure to hyperosmotic culture conditions for 5 h
Ofﬁcial symbol Gene name Mean fold change
(95% conﬁdence interval)
P value* ARE
clustery
Upregulated PTGS2 Prostaglandin-endoperoxide synthase 2
(prostaglandin G/H synthase and cyclo-oxygenase)
5.56 (2.27) 0.04 3
CCL2 Chemokine (CeC motif) ligand 2 5.35 (1.84) 0.081 None
IBRDC1 IBR domain containing 1 5.29 (1.36) 0.000005 None
ARNTL Aryl hydrocarbon receptor nuclear translocator-like 5.08 (0.62) 0.000038 None
GLS Glutaminase 4.74 (0.96) 0.0000001 3
HS3ST3A1 Heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 4.69 (0.46) 0.002 None
BAMBI Bone morphogenetic protein (BMP) and activin
membrane-bound inhibitor homolog
(Xenopus laevis)
4.46 (1.77) 0.000688 None
PGM2L1 Phosphoglucomutase 2-like 1 4.37 (1.02) 0.000313 5
SGK Serum/glucocorticoid regulated kinase 3.85 (0.91) 0.001 None
NLF2 Nuclear localized factor 2 3.82 (1.08) 0.098 None
PRSS35 Protease, serine, 35 3.79 (0.92) 0.000681 5
DDIT4L DNA-damage-inducible transcript 4-like 3.77 (0.18) 0.0000003 None
ACPL2 Acid phosphatase-like 2 transcript variant 1 3.76 (0.35) 0.000073 None
IL6 Interleukin 6 (interferon, beta-2) 3.69 (1.49) 0.16 5
TGFB3 Transforming growth factor beta 3 3.68 (0.57) 0.000075 None
SLC6A12 Solute carrier family 6 (neurotransmitter transporter,
betaine/GABA), member 12
3.57 (0.99) 0.006 None
GEM GTP binding protein overexpressed in skeletal muscle 3.52 (1.16) 0.001 5
SSTR2 Somatostatin receptor 2 3.42 (0.63) 0.004 None
GRAMD3 GRAM domain containing 3 3.32 (0.25) 0.000136 None
HSPH1 Heat shock 105 kDa/110 kDa protein 1 3.17 (0.89) 0.00003 5
GSPT1 G1 to S phase transition 1 3.13 (0.13) 0.000168 None
NIN Ninein, GSK3B interacting protein transcript variant 4 3.13 (0.71) 0.000508 3
MRPS24 Mitochondrial ribosomal protein S24 nuclear gene encoding
mitochondrial protein
3.09 (0.32) 0.000681 None
PFKFB3 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 3.08 (0.60) 0.000014 3
RGS16 Regulator of G-protein signalling 16 3.03 (0.90) 0.006000 4
SLC31A2 Solute carrier family 31 (copper transporters), member 2 2.99 (0.46) 0.000219 None
UNQ1940 HWKM1940 (UNQ1940) 2.99 (1.13) 0.038000 None
PPT2 Palmitoyl-protein thioesterase 2 transcript variant 2 2.99 (0.27) 0.000370 None
COBLL1 COBL-like 1 (COBLL1) 2.99 (0.36) 0.000003 5
HSPB2 Homo sapiens heat shock 27 kDa protein 2 2.95 (0.49) 0.007 None
Downregulated C10ORF10 Chromosome 10 open reading frame 10 4.41 (0.39) 0.0000487 3
UBASH3B Ubiquitin associated and SH3 domain containing B 3.89 (0.22) 0.00078 None
PMP22 Peripheral myelin protein 22, transcript variant 2 3.18 (0.44) 0.0000833 None
MT1M Metallothionein 1M 3.17 (0.45) 0.0000141 None
MT1P Metallothionein 1I (pseudogene) 3.16 (0.96) 0.0002433 3
KLF6 Kruppel-like factor 6, transcript variant 2 3.043 (0.34) 0.0003679 None
MAFB V-maf musculoaponeurotic ﬁbrosarcoma oncogene
homolog B (avian)
3.01 (0.80) 0.002 None
CREB5 cyclic adenosine monophosphate (cAMP) responsive element
binding protein 5, transcript variant 1
2.88 (0.92) 0.01 5
ZMiZ1 Zinc ﬁnger, MIZ-type containing 1 2.86 (0.13) 0.0001986 None
ARHGEF3 Rho guanine nucleotide exchange factor (GEF) 3 2.80 (0.87) 0.001 None
TMEM173 Transmembrane protein 173 2.64 (0.37) 0.0002399 5
TSC22D1 TSC22 domain family, member 1 transcript variant 2 2.62 (0.33) 0.032 None
CYR61 Cysteine-rich, angiogenic inducer, 61 2.57 (0.24) 0.017 None
CBR3 Carbonyl reductase 3 2.53 (0.16) 0.0007419 5
ALDH3A2 Aldehyde dehydrogenase 3 family, member A2,
transcript variant 1
2.51 (0.49) 0.001 None
ABCB9 ATP-binding cassette, sub-family B (MDR/TAP),
member 9, transcript variant 4
2.44 (0.33) 0.021 None
RBPMS2 RNA binding protein with multiple splicing 2 2.44 (0.24) 0.002 5
EEF2K Eukaryotic elongation factor-2 kinase 2.43 (0.45) 0.001 None
PIK3IP1 Phosphoinositide-3-kinase interacting protein 1 2.42 (0.45) 0.001 None
CLDN23 Claudin 23 2.28 (0.28) 0.004 5
NUP37 Nucleoporin 37 kDa 2.27 (0.22) 0.0000766 None
PLCD1 Phospholipase C, delta 1 2.26 (0.20) 0.025 3
PHLDA1 Pleckstrin homology-like domain, family A, member 1 2.24 (0.75) 0.002 None
ADRB2 Adrenergic, beta-2-, receptor, surface 2.24 (0.79) 0.152 3
RALGDS Ral guanine nucleotide dissociation stimulator
(RALGDS), transcript variant 1
2.22 (0.54) 0.058 4
SP110 SP110 nuclear body protein, transcript variant c 2.18 (0.23) 0.0000246 None
ROR2 Receptor tyrosine kinase-like orphan receptor 2 2.17 (0.29) 0.013 None
C5ORF4 Chromosome 5 open reading frame 4, transcript variant 1 2.16 (0.50) 0.003 None
WDR70 WD repeat domain 70 2.14 (0.15) 0.0000146 5
ANGPTL2 Angiopoietin-like 2 2.13 (0.23) 0.212 None
* Paired t test.
y ARE cluster category as deﬁned by the ARED database.
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Fig. 1. Exposure to hyperosmotic conditions leads to increases in mRNAs enriched with ARE-containing genes. (A) Pie charts illustrating the occurrence of ARE’s in genes signiﬁcantly
upregulated (P< 0.01, uncorrected paired t test) following 5 h exposure to hyperosmotic conditions. Different classes of AREs are categorised according to the ARED cluster system.
(B) Hierarchical clustering analysis of genes upregulated 1.4-fold after a 5 h exposure to hyperosmolarity. Columns show all combinations of individual treatments (C e control, H e
hyperosmotic) and samples (samples areMemale or Fe female,with age denoted afterward). Green in the rightmost column indicates thepresence of anARE in the genes 30UTR. (C) Real
time PCR analysis of expression of 15 candidate genes chosen for further examination. Bars represent means with 95% conﬁdence intervals. All genes except SLC5A3 demonstrated
upregulation that was signiﬁcant (*P values: COBLL1<0.001, RGS16¼ 0.007, PGM2II< 0.001, GLS¼ 0.006, PFKFB3¼ 0.017, GEM¼ 0.006, IL6¼ 0.009, HSPH1<0.001, ADAMTS1¼0.009,
ARNTL< 0.001, BAMBI¼ 0.007, COX2¼ 0.001, SGK1<0.001, SLC5A3¼ 0.227) using paired t tests (data is derived from experiments carried out with four separate donors).
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mycin D chase analysis. In each donor the transcripts for nine out of
the 14 genes examined decayed more slowly when cultured in
hyperosmotic media. Decay curves showing values averaged from
these donors are shown in Fig. 3. The average half-life of
the RNA under each condition was as follows: ADAMTS1 (t1/2
380 mOsm ¼ 2.5 h, t1/2 550 mOsm ¼ 4.6 h), ARNTL (t1/2
380mOsm¼ 5.7 h, t1/2 550 mOsm¼ 18 h), BAMBI (t1/2 380
mOsm¼ 1.9 h, t1/2 550 mOsm¼ 3.5 h), COBLL1 (t1/2 380
mOsm¼ 4.6 h, t1/2 550 mOsm¼ 15 h), PTGS2 (t1/2 380mOsm¼
3.3 h, t1/2 550 mOsm¼ 16 h), GEM (t1/2 380 mOsm¼ 1.1 h, t1/2 550
mOsm¼ 2.3 h), HSPH1 (t1/2 380 mOsm¼ 7.4 h, t1/2 550 mOsm
> 20 h), PFKFB3 (t1/2 380mOsm¼ 3.0 h, t1/2 550 mOsm¼ 5.4 h),
SLC5A3 (t1/2 380mOsm¼ 7.9 h, t1/2 550 mOsm¼ 28 h). RNA
decay rates of ﬁve of the geneswere not altered by hyperosmolarity.Three of these e IL6, RGS16 and SGK e had rapid rates
of RNA turnover (t1/2< 3 h) whilst two of them e GLS and
PGML2 e had slower rates of mRNA decay (t1/2¼ 6 and >20 h
respectively).
Hyperosmotic induction of gene expression is blocked by MAPK
inhibitors
We have previously shown that p38MAPK is activated following
exposure of HAC to hyperosmotic conditions and we observed in
this study that the ERK1/2 is similarly activated [Fig. 4(A, B)].
Focussing on ﬁve of the post-transcriptionally regulated genes
identiﬁed (ADAMTS1, ARNTL, BAMBI, GEM, PFKFB3), we examined
whether their induction under hyperosmotic conditions was
inﬂuenced by pharmacological inhibition of the p38 MAPK or
Table II
Top 10 hyperosmotically regulated genes in enriched pathways mapped using IPA
Pathway Gene Gene symbol Fold change*
VDR MAX dimerization protein 1 MXD1 1.95
Nuclear receptor coactivator 3 NCOA3 1.85
Cyclin-dependent kinase inhibitor 1A (p21, Cip1) CDKN1A 1.68
E1A binding protein p300 EP300 1.47
Kruppel-like factor 4 (gut) KLF4 1.47
Protein kinase C, alpha PRKCA 1.45
CCAAT/enhancer binding protein (C/EBP), beta CEBPB 1.51
Serpin peptidase inhibitor, clade B (ovalbumin), member 1 SERPINB1 1.64
Forkhead box O1 FOXO1A 2.00
Growth arrest and DNA-damage-inducible, alpha GADD45A 2.03
p38 MAPK Transforming growth factor, beta 3 TGFB3 3.67
Heat shock 27 kDa protein 2 HSPB2 2.94
Interleukin-1 receptor-associated kinase 2 IRAK2 1.98
Mitogen-activated protein kinase-activated protein kinase 2 MAPKAPK2 1.78
Activating transcription factor 2 ATF2 1.73
Dual speciﬁcity phosphatase 1 DUSP1 1.64
Activating transcription factor 4 (tax-responsive enhancer element B67) ATF4 1.54
Myocyte enhancer factor 2D MEF2D 1.90
Eukaryotic elongation factor-2 kinase EEF2K 2.43
cAMP responsive element binding protein 5 CREB5 2.88
HGF Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclo-oxygenase) PTGS2 5.53
E74-like factor 1 (ets domain transcription factor) ELF1 1.80
Activating transcription factor 2 ATF2 1.72
Cyclin-dependent kinase inhibitor 1A (p21, Cip1) CDKN1A 1.68
Jun proto-oncogene JUN 1.54
Rap guanine nucleotide exchange factor (GEF) 1 RAPGEF1 1.60
E74-like factor 3 (ets domain transcription factor, epithelial-speciﬁc) ELF3 1.64
Phospholipase C, gamma 2 (phosphatidylinositol-speciﬁc) PLCG2 1.70
PTK2 protein tyrosine kinase 2 PTK2 1.73
Mitogen-activated protein kinase kinase kinase 4 MAP3K4 1.73
ERK1/2 Serum/glucocorticoid regulated kinase 1 SGK 3.85
Epidermal growth factor receptor EGFR 2.03
Activating transcription factor 2 ATF2 1.72
Activating transcription factor 4 (tax-responsive enhancer element B67) ATF4 1.54
FBJ murine osteosarcoma viral oncogene homolog FOS 1.52
Myocyte enhancer factor 2C MEF2C 1.49
Myocyte enhancer factor 2D MEF2D 1.90
Forkhead box O3 FOXO3A 2.12
cAMP responsive element binding protein 5 CREB5 2.88
TGFb Transforming growth factor, beta 3 TGFB3 3.67
TGFB-induced factor homeobox 1 TGIF1 2.57
Jun proto-oncogene JUN 1.54
FBJ murine osteosarcoma viral oncogene homolog FOS 1.52
CREB binding protein CREBBP 1.49
Transcription factor binding to IGHM enhancer 3 TFE3 1.44
Transforming growth factor, beta receptor II (70/80 kDa) TGFBR2 1.41
TGFb activated kinase 1/MAP3K7 binding protein 1 MAP3K7IP1 1.41
SMAD family member 3 SMAD3 1.57
SMAD family member 6 SMAD6 2.09
* Positive numbers indicate an increase following exposure to 550 mOsm culture condition for 5 h as described in Materials and methods, whilst negative values indicate
a fold decrease under the same conditions.
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SB202190 blocked the induction of ADAMTS1 and PFKFB3 by
hyperosmolarity but had no statistically signiﬁcant effect on the
other three genes [Fig. 4(C)]. However, the MEK1/2 inhibitor U0126
signiﬁcantly inhibited the induction of all hyperosmotically-
induced genes except PFKFB3 [Fig. 4(D)]. Neither inhibitor
affected gene expression under 380 mOsm conditions (data not
shown).
Regulation of HAC miRNA levels by hyperosmolarity
Using the same RNA samples from our microarray gene
expression analysis we screened miRNA microarrays. We analysed
differential regulation of the miRNAs by hyperosmolarity using
paired t tests.We found only onemiRNAwas signiﬁcantly regulated
when we speciﬁed a low P value (P< 0.001) which was miR-382with an average increase of 1.7-fold in hyperosmotic conditions.
To obtain a greater pool of potentially regulated genes we relaxed
our analysis and included miRNAs regulated with P< 0.05. This
approach identiﬁed 38 miRNAs which were up or downregulated
consistently in all four donors (Fig. 5). Of these, in addition to miR-
382, the most strongly miRNAs upregulated by hyperosmolarity
were miR-29b-1 (1.8-fold), miR27a* (1.7-fold), miR-23a* (1.5-fold)
and miR-433 (1.4-fold). Hyperosmolarity downregulated some
miRNAs but only by small levels. The most strongly downregulated
was miR-136 which was only reduced by 1.3-fold.
Discussion
In this study we have built on previous ﬁndings which showed
that HAC are able to regulate the rate of mRNA decay of the
important cartilage marker genes SOX9 and COL2A1 following
Fig. 2. IPA of hyperosmotically regulated genes identiﬁed enrichment ion those associated with TGFb signalling. Schematic demonstrating enrichment of hyperosmotically
regulated genes within the TGFb signalling pathway. Red indicates upregulation (>1.4-fold) and green downregulation (>1.4-fold). Grey indicates signiﬁcantly regulated genes
controlled between 1.1- and 1.4-fold. Stronger colour intensity indicates stronger regulation of each gene.
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exposed HAC to hyperosmotic conditions and examined tran-
scriptome regulation, aiming to identify genes regulated post-
transcriptionally. We have taken signiﬁcantly regulated genes and
examined them for the presence of AREs in their 30UTRs using the
ARED database. This database lists AREs and classiﬁes them into
one of ﬁve deﬁned clusters based on the frequency and arrange-
ment of the AUUUA motifs. By using this approach we have been
able to identify a number of upregulated genes whose mRNA decay
rates are slower after exposure to hyperosmotic conditions.
One of the most interesting ﬁndings is the range of different
genes that can be controlled post-transcriptionally by articular
chondrocytes. Genes such as PTGS2 (which encodes the cyclo-
oxygenase 2 enzyme) and the proteinase ADAMTS1 have been
described extensively in cartilage biology with PTGS2 also having
well characterised post-transcriptional responses to cytokine and
stress stimuli16,20,21. These genes would be associated with cata-
bolic changes in cartilage, contributing to the breakdown of the
ECM. This would appear to indicate that altered osmolarity in
cartilage due to compressive load and/or ECM breakdown could
have a downstream effect on chondrocyte catabolism. As would be
expected, a number of the genes that were regulated encode stress
response proteins. The solute transporter SLC5A3 is also known as
SMIT1 and encodes a myoinositol transporter that performs a well-
described function in cellular osmoresponsiveness. Reports have
previously shown that myoinositol transport is regulated following
osmotic stress in chondrocytes. It has already been demonstrated
that its expression is upregulated in chondrocyte-like nucleus
pulposus cells from both human and rat intervertebral disc
following hyperosmotic challenge22,23. However, given the lack of
statistical evidence for the signiﬁcance of the regulation of thisgene in the real time PCR quantitation, further analysis may be
required before we can conﬁrm that it is regulated in the experi-
mental conditions described here. Another stress responsive gene,
heat shock protein HSPH1 appears to act as a molecular chaperone
but there have been no previous reports of its regulation in articular
chondrocytes24.
The use of IPA analysis has allowed us to identify a range of
cellular processes where a signiﬁcant number of genes, regulated
both strongly and more subtly, are enriched. Not surprisingly,
processes related to cell stress responses, such as p38 MAPK, have
been identiﬁed. In addition other well established pathways, such
as ERK1/2, HGF and TGFb were identiﬁed. Given the fundamental
nature of a dynamic osmotic environment to chondrocytes, future
investigation of these, and other processes uncovered by IPA, is
clearly warranted.
In addition to genes familiar to the cartilage biology ﬁeld there
are some other genes whose post-transcriptional regulation is
intriguing. The gene BAMBI encodes a transmembrane pseudor-
eceptor which shares homology with the type I TGFb receptors. It is
able to regulate TGFb signalling in a number of processes and
species. Its altered expression ﬁts in with an overall enrichment in
TGFb related gene regulation by hyperosmolarity, which we were
able to identify using IPA. The purpose of altered TGFb respon-
siveness following exposure to increased osmolarity is of interest.
In our cultures, hyperosmolarity increases TGFb3 expression but
also increases the antagonist BAMBI. Moreover, the expression of
the type I TGFb receptor is itself decreased as well as genes
encoding some signalling intermediate proteins such as the TGFb
activated kinase binding protein TAB1 and SMAD3. Interestingly
Smad7, which acts as an intercellular BMP signalling inhibitor, is
also downregulated. Given the well established roles for
Fig. 3. Hyperosmolarity regulates a diverse set of chondrocyte genes at the post-transcriptional level. RNA decay curves generated from actinomycin D chase experiments. Freshly
isolated HAC were treated under control (380 mOsm, diamonds) or hyperosmotic (550 mOsm, squares) conditions for 2 h and then actinomycin D was added to the media. mRNA
levels were then determined at 0, 1, 3 and 5 h by qRT-PCR. Data points represent the average of decay curves obtained from two different donors e bars represent 95% conﬁdence
interval.
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will be interesting to investigate how these two signals interact in
future studies.
We found evidence that hyperosmotic conditions also post-
transcriptionally modulate a number of signalling processes that do
not have an established role in chondrocyte biology This included
regulation of molecules such as the small GTPase GEM which is
thought to be involved in receptor mediated signal transduction and
the putative actin binding protein COBLL1 which is expressed in the
developing mouse limb bud and has been suggested to perform
a signalling scaffold function25. One of the most interesting genes
regulated at the post-transcriptional level was ARNTL. This gene
encodes a protein related to the Aryl hydrocarbon receptor, which
plays a critical role in the regulation of circadian rhythms26. Its strong
regulation by hyperosmolarity led us to include it in our RNA decay
analysis despite it not being identiﬁed by ARED and also not having
any AREs identiﬁed through manual inspection. The fact that its
mRNA decay rates were altered by hyperosmolarity, combined with
the lack of similar regulation of ARE-containing mRNAs such as IL6,SGK and RGC32, demonstrates that our approach to identifying
potential post-transcriptionally regulated genes is not deﬁnitive and
that targets must be validated in the laboratory.
It is interesting that the enrichment of ARE-containing upre-
gulated genes occurred through the increase in mostly cluster
5 AREs. In a previous study we had identiﬁed post-transcriptional
control of the SOX9 and COL2A1 mRNAs in hyperosmotically
stimulated chondrocytes, both of which harbour cluster 5 AREs.
This motif, deﬁned by ARED as WWWU[AUUUA]UWWW is the
most common motif identiﬁed in known 30UTR sequences and is
often found in transcription factors and cell cycle regulatory
proteins whereas other types of ARE-containing overlapping mul-
timeric AUUUA motifs are generally found in cytokines mRNAs27.
Thus, hyperosmolarity seems to cause post-transcriptional gene
regulation primarily in mRNAs containing dispersed, individual
AREs. It is still unclear though to what extent post-transcriptional
control is controlling the overall mRNA levels. Many genes whose
expression can be radically altered by changing mRNA decay rates
contain multimeric overlapping AREs27 which weren’t enriched in
Fig. 4. Increased expression of hyperosmotically regulated chondrocyte genes requires
MAPK signalling. Western blot analysis of (A) phosphorylated and total ERK1/2 and
(B) phosphorylated p38 MAPK and GAPDH in freshly isolated HAC cultured for 5 h
under 380 or 550 mOsm conditions. Real time PCR analysis of freshly isolated HAC
grown for 5 h in hyperosmotic conditions in the presence or absence of (C) the p38
MAPK inhibitor SB202190 or (D) the MEK1/2 inhibitor U0126. Vertical axis represents
fold change vs HAC cultured in 380 mOsm conditions. Bars indicate mean and 95%
conﬁdence intervals of data from four (SB202190) or ﬁve (U0126) independent
experiments. *P< 0.05 vs without inhibitor, paired t test.
Fig. 5. miRNAs are not strongly regulated following 5 h exposure to hyperosmolarity.
Heat map illustrating the expression of those miRNAs that demonstrated a change in
expression within a 95% conﬁdence interval following hyperosmotic stimulation.
Donor (M¼male, F¼ femaleþ age) is denoted at top of each column as well as
treatment (380 mOsm or 550 mOsm). The data has been subjected to hierarchical
clustering.
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function is critically controlled by its mRNA decay rates28. It is
possible therefore that for many of the genes identiﬁed here, post-
transcriptional regulation does not switch gene expression on and
off but rather provides a means of ﬁne-tuning expression levels in
response to the external stimuli.
Our previous work also demonstrated that SOX9 mRNA upregu-
lation by hyperosmolarity in HAC and in equine articular chon-
drocytes can be inhibited by blocking the p38 MAPK and ERK1/2
pathways10,29. Also, both of these pathways have been implicated in
the transduction of hyperosmotic signals into increased chondrocyte
ECM synthesis30 and also control cellular response to elevated
osmolarity in other systems31,32.We chose to examine a subset of ﬁve
mRNAs conﬁrmed to be post-transcriptionally regulated in Fig. 4.
ThesemRNAswere chosen as theyencode proteinswith awide range
of functions. Of the ﬁve, the hyperosmotic induction of two
(ADAMTS1 and PFKFB3) was sensitive to p38MAPK inhibitionwhilst
all except PFKFB3 were sensitive to MEK/ERK inhibition. Therefore,
these pathways appear to play roles in chondrocyte osmosensing,
with the potential to inﬂuence wide ranging cellular processes, in
addition to their modulation of ECM synthesis under the same
conditions30. It will be interesting to see whether these pathways
modulate mRNA decay rates following hyperosmotic stimulation,
perhaps through their ability to regulate downstream RNA binding
proteins33. We expanded our mechanistic studies to examine how
chondrocyte miRNAs, which are key regulators of post-transcrip-
tional gene regulation,were affected by hyperosmolarity.We found itrevealing that our screen of miRNA regulation by hyperosmolarity
did not reveal a substantial change in expression for any of these
molecules. The experiments in this study are limited to a static
application of hyperosmolarity and so at present we can’t rule out
that the miRNA response would be different in the dynamically
changing osmotic environment experienced by the cells in vivo. The
only miRNA that showed a robust statistical regulation by
S.R. Tew et al. / Osteoarthritis and Cartilage 19 (2011) 1036e1046 1045hyperosmolarity was miR-382 although it was only upregulated by
70%. miR-382 binds to the 30 ends of human immunodeﬁciency virus
(HIV) mRNAs and is enriched in resting CD4þ T cells34 as well as
being associated with lymphoma and massive macronodular adre-
nocortical disease35,36. Apart from its role in HIV RNA binding, there
are as yet no deﬁned roles for miR-382 although a recent study has
demonstrated that it is an unusually short lived miRNA37. The
cartilage-speciﬁcmiR-14038,39was among themost highly expressed
miRNAs observed in this study (data not shown) although not
regulated by osmolarity. Our data indicates that regulation of miRNA
levels is not a signiﬁcant part of the immediate hyperosmotic
response in chondrocytes. This is not the case however in other cell
systems, such as renal medullary epithelial cells which rapidly
regulate miRNAs following exposure to high salinity40. Therefore
furtherwork, particularly focussing on the role ofmiR-382 in osmotic
sensitivity, is warranted before fully excluding a role for miRNAs in
chondrocyte hyperosmotic transduction.
We have demonstrated that a number of genes encoding
proteins with varying properties are regulated post-transcription-
ally by HAC following hyperosmotic challenge, a process that occurs
more rapidly than previously identiﬁed ECM regulation under the
same conditions30. Given the wealth of osmotic, oxidative and
hypoxic stresses that chondrocytes reside under in the synovial
joint it is likely that such post-transcriptional responses are being
employed as they respond to alterations in their environment.
Future work should shed more light on the genes and cellular
processes controlled by chondrocytes in this way and the extent to
which such control leads to either strong regulation or subtle ﬁne-
tuning of the transcriptome.Author contributions
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